Chronic kidney disease: Why is current management uncoordinated and suboptimal?

Nephrology Dialysis Transplantation

Volumn 16, Issue SUPPL. 7, 2001, Pages 61-64

  Valderrábano, Fernando ^a   Golper, Thomas ^b   Muirhead, Norman ^c   Ritz, Eberhard ^d   Levin, Adeera ^e  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anaemia; Chronic kidney disease; Collaboration; Communication; Education; End stage renal disease

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; COST OF ILLNESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MEDICAL SPECIALIST; MEDICAL TECHNOLOGY; MORBIDITY; MORTALITY; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035167129     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.suppl_7.61     Document Type: Article

References (7)

1. Patient mortality and survival
2. Estudio epidemiologico español sobre el tratamiento de la anemia en pacientes con insuficiencia renal progresiva
3. European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure
4. The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey
5. European Best Practice Guidelines 1-4: Evaluating anaemia and initiating treatment
6. Estimating the number of patients and medicare cost for end-stage renal disease in the US to the year 2010